CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 47 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,203 | +18.8% | 39,790 | -7.6% | 0.00% | – |
| Q2 2023 | $63,276 | -24.6% | 43,045 | 0.0% | 0.00% | – |
| Q1 2023 | $83,938 | -56.7% | 43,045 | -50.0% | 0.00% | – |
| Q4 2022 | $193,702 | +86.3% | 86,090 | +100.0% | 0.00% | – |
| Q3 2022 | $104,000 | +16.9% | 43,045 | 0.0% | 0.00% | – |
| Q2 2022 | $89,000 | -25.2% | 43,045 | +2.4% | 0.00% | – |
| Q1 2022 | $119,000 | -61.2% | 42,045 | -36.1% | 0.00% | – |
| Q4 2021 | $307,000 | +279.0% | 65,790 | +368.5% | 0.00% | – |
| Q3 2018 | $81,000 | -1.2% | 14,044 | +4.1% | 0.00% | – |
| Q2 2018 | $82,000 | +7.9% | 13,490 | +19.8% | 0.00% | – |
| Q1 2018 | $76,000 | +1.3% | 11,258 | +12.1% | 0.00% | – |
| Q4 2017 | $75,000 | +47.1% | 10,046 | -11.9% | 0.00% | – |
| Q2 2014 | $51,000 | -15.0% | 11,400 | -13.6% | 0.00% | – |
| Q1 2014 | $60,000 | -91.5% | 13,200 | -92.0% | 0.00% | – |
| Q4 2013 | $702,000 | +688.8% | 164,077 | +741.4% | 0.00% | – |
| Q3 2013 | $89,000 | -19.8% | 19,500 | -11.0% | 0.00% | – |
| Q2 2013 | $111,000 | – | 21,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,218,401 | $6,957,000 | 4.07% |
| BARD ASSOCIATES INC | 395,575 | $2,260,000 | 0.21% |
| Ariel Investments | 1,290,317 | $7,368,000 | 0.08% |
| Ballew Advisors, Inc | 5,557 | $31,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,400 | $1,173,000 | 0.01% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $68,000 | 0.01% |
| Oakworth Capital, Inc. | 3,052 | $17,000 | 0.00% |
| Spark Investment Management LLC | 10,800 | $61,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 878,348 | $5,015,000 | 0.00% |
| Renaissance Technologies | 381,471 | $2,178,000 | 0.00% |